Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Overview of attention for article published in Nature Immunology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#1 of 4,257)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 179 news outlets
blogs: 20 blogs
twitter: 14379 X users
patent: 4 patents

facebook: 6 Facebook pages
reddit: 22 Redditors
video: 4 YouTube creators

Citations

dimensions_citation: 574 Dimensions

Readers on

mendeley: 561 Mendeley

Summary News Blogs X Patents Facebook Reddit YouTube Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF

Application WO-2023213400-A1

World Intellectual Property Organisation (WIPO)

ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF

Application WO-2023213911-A2

World Intellectual Property Organisation (WIPO)

ENRICHMENT AND CHARACTERIZATION OF RARE CIRCULATING CELLS, INCLUDING PROGENITOR CELLS…

Application WO-2023150760-A2

World Intellectual Property Organisation (WIPO)

MEK INHIBITORS FOR THE PREVENTION AND TREATMENT OF LONG COVID SYNDROME

Application WO-2023094556-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.